Industrial Machinery & Robotics Global On demand · 24-48h

Global Modular PSA Oxygen Generator Market Strategic Research Report

Global Modular PSA Oxygen Generator Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Modular PSA Oxygen Generator Market
$2452025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Industrial 90%–95% Oxygen System, Medical 93%±3% Oxygen System

By Application: Hospitals & Healthcare Facilities, Aquaculture, Industrial, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: CAIRE, NOVAIR, OXYMAT, Oxywise, PCI Gases, On Site Gas Systems, NOXERIOR, SYSADVANCE, INMATEC, Atlas Copco, MVS Engineering, Longfian Scitech, CAN GAS Systems, Chengdu Lianbang Medical Technology, Hangzhou Medoxygen Technology, WEGO, Sumitomo Seika Chemicals, Shinko Airtech, OXUS Co., Ltd., JuvAir

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 138 pages
Market size 2025
$245
Million USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$358.8
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Modular PSA Oxygen Generator market size is predicted to grow from US$ 245 million in 2025 to US$ 357 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

A modular PSA oxygen generator is an on-site oxygen production system that uses compressed ambient air and pressure swing adsorption to separate nitrogen through molecular sieve beds and continuously produce oxygen-enriched gas. Its key feature is modular scalability: adsorption modules, valves, controls, buffer tanks, monitoring systems, and optional boosters or filling stations can be combined or expanded according to required flow, purity, pressure, and application. Typical oxygen purity is around 90%–95%, while medical applications commonly use 93%±3% oxygen.

The upstream supply chain includes air compressors, refrigerated or desiccant dryers, filters, zeolite molecular sieves, adsorption vessels, pneumatic or solenoid valves, oxygen buffer tanks, oxygen analyzers, dew-point meters, pressure and flow sensors, PLC/HMI controls, electrical cabinets, boosters, cylinder-filling manifolds, piping and valves, skid bases, and containerized structures.Midstream players are PSA equipment manufacturers and system integrators, while downstream users include hospitals, clinics, aquaculture farms, wastewater plants, ozone systems, gold mining, metallurgy, glass, chemicals, food fermentation, and emergency oxygen projects.

In 2025, global modular PSA oxygen generator production reached approximately 50 k units, with an average global market price is $5,000 per unit.

Modular PSA Oxygen Generators are on-site oxygen generation systems built around pressure swing adsorption technology and standardized oxygen-production modules. Their defining value lies not simply in oxygen generation itself, but in the ability to support phased configuration, future expansion, and redundant deployment. Compared with conventional integrated PSA systems, this category places greater emphasis on modular scalability, installation flexibility, rapid commissioning, and expandable capacity across different use cases. Public supplier materials show that modular systems are already widely positioned for healthcare, wastewater treatment, aquaculture, mining, and other applications requiring continuous oxygen supply, with key features such as expansion by adding modules, online monitoring, Modbus communication, and continuous high-purity oxygen output.

Market growth is being driven mainly by user demand for supply autonomy, scalable capacity, and stronger supply-chain resilience. In healthcare, modular systems are especially suitable for central oxygen projects where future demand may grow in stages; in industrial settings, they fit pilot installations, variable demand, and phased capacity ramp-up. Public sources consistently emphasize that modular PSA systems can be upgraded by adding modules or by operating dual-bank configurations in parallel, while also offering advantages in lifecycle cost, site adaptability, and future expansion convenience. This indicates that competition is shifting beyond simple oxygen generation capability toward broader system scalability, reliability, and lifecycle economics.

In development terms, modular PSA oxygen generators are evolving from conventional on-site oxygen units into more integrated solutions built around standardized modules, remote monitoring, rapid deployment, and multi-scenario integration. Recent public product positioning clearly reflects this direction: suppliers are strengthening modular expansion, dual-bank configuration, and phased project implementation on one side, while also increasing emphasis on online monitoring, communication interfaces, and integration with cylinder-filling systems or hospital pipeline networks on the other. Going forward, the category is likely to continue benefiting from localized medical oxygen infrastructure, industrial efficiency targets, and staged project construction, while competition becomes more focused on module standardization, ease of maintenance, digital monitoring capability, and expansion efficiency.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Modular PSA Oxygen Generator market?

What factors are driving Modular PSA Oxygen Generator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Modular PSA Oxygen Generator market opportunities vary by end market size?

How does Modular PSA Oxygen Generator break out by Type, by Application?

This report presents a comprehensive overview of the global Modular PSA Oxygen Generator market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Industrial 90%–95% Oxygen System
  • Medical 93%±3% Oxygen System

Segment by System Configuration

  • Skid-mounted Oxygen Generator
  • Containerized Oxygen Generator
  • Others

Segment by Oxygen Production Capacity

  • Small Modular PSA Generator
  • Medium Modular PSA Generator
  • Large Modular PSA Generator

Segment by Application

  • Hospitals & Healthcare Facilities
  • Aquaculture
  • Industrial
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Modular PSA Oxygen Generator market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals & Healthcare Facilities, Aquaculture, Industrial evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Modular PSA Oxygen Generator Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$245
2025
Forecast
$358.8
2032
CAGR
5.6%
2025–2032
Regiões
5
global
Key companies
CAIRENOVAIROXYMATOxywisePCI GasesOn Site Gas SystemsNOXERIORSYSADVANCE
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Industrial 90%–95% Oxygen SystemMedical 93%±3% Oxygen System
By Application
Hospitals & Healthcare FacilitiesAquacultureIndustrialOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Industrial 90%–95% Oxygen System
  • 3.1.3 Medical 93%±3% Oxygen System
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals & Healthcare Facilities
  • 4.1.3 Aquaculture
  • 4.1.4 Industrial
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 CAIRE
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 NOVAIR
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 OXYMAT
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Oxywise
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 PCI Gases
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 On Site Gas Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 NOXERIOR
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SYSADVANCE
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 INMATEC
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Atlas Copco
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 MVS Engineering
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Longfian Scitech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 CAN GAS Systems
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Chengdu Lianbang Medical Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hangzhou Medoxygen Technology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 WEGO
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Sumitomo Seika Chemicals
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shinko Airtech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 OXUS Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 JuvAir
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Modular PSA Oxygen Generator market size?
The global Modular PSA Oxygen Generator market is estimated at US$ 245 million in 2025 (base year) and is projected to reach US$ 357 million by 2032.
What growth rate is expected for the Modular PSA Oxygen Generator market through 2032?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 245 million in 2025 to US$ 357 million in 2032, roughly 1.5 times its base-year value.
How is Modular PSA Oxygen Generator defined?
A modular PSA oxygen generator is an on-site oxygen production system that uses compressed ambient air and pressure swing adsorption to separate nitrogen through molecular sieve beds and continuously produce oxygen-enriched gas. Its key feature is modular scalability: adsorption modules, valves, controls, buffer tanks, monitoring systems, and optional boosters or filling stations can be combined or expanded according to required flow, purity, pressure, and application.
What are the main segments of the Modular PSA Oxygen Generator market by type?
By type, the market is segmented into Industrial 90%–95% Oxygen System and Medical 93%±3% Oxygen System.
Which applications drive demand in the Modular PSA Oxygen Generator market?
Key applications covered include Hospitals & Healthcare Facilities, Aquaculture, Industrial and Others.
Who are the key players in the Modular PSA Oxygen Generator market?
Key players profiled include CAIRE, NOVAIR, OXYMAT, Oxywise, PCI Gases, On Site Gas Systems, NOXERIOR and SYSADVANCE, among 20 companies covered in total.
Which regions and countries are covered for Modular PSA Oxygen Generator?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Modular PSA Oxygen Generator market?
Market growth is being driven mainly by user demand for supply autonomy, scalable capacity, and stronger supply-chain resilience.
Who should buy the Modular PSA Oxygen Generator market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals & Healthcare Facilities, Aquaculture and Industrial, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Modular PSA Oxygen Generator market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.